Agendia N.V.

Agendia is active in gene expression analysis-based cancer diagnostics, by unlocking essential information on the risk of cancerous spread, cancer recurrence, the response to certain drugs or the primary site of a tumor. In addition, Agendia's expertise in gene expression profiling offers opportunities for pharmaceutical companies to improve their drug development tracks. The principal activities of the company are: to provide diagnostics, mainly in the field of cancer; to facilitate the development of new medecine.